Abstract
Vasovagal syncope (VVS) is known to have a benign prognosis and be associated with enhanced contraction and activation of the left ventricular (LV) mechanoreceptors. However, a little is known about VVS in patients with LV dysfunction. The present study aimed to investigate the prevalence and prognosis of VVS in patients with LV dysfunction. We enrolled 368 patients with unexplained syncope. In 7 of these patients, LV ejection fraction was lower than 40%. The results of a head-up tilt test (HUT) and the recurrence of syncope were compared between these 7 patients with LV dysfunction and the remaining patients. Positive HUT was obtained in the 6 patients (86%) with LV dysfunction; this rate tended to be higher as compared with normal cardiac function (192/361, 53%, P = 0.069). In patients with LV dysfunction, response in HUT was mostly vasodepressor type (62%); however, most of HUT responses were mixed type in patients with normal LV function (67%). Among patients with positive HUT, the recurrent rate of syncope after HUT was higher in those with LV dysfunction than in those with normal LV function (67 vs. 21%, P = 0.008). VVS in patients with LV dysfunction may be refractory to treatment and could be associated with poor prognosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D (2002) Incidence and prognosis of syncope. N Engl J Med 347:878–885
Benditt DG, Remole S, Bailin S, Dunnigan A, Asso A, Milstein S (1991) Tilt table testing for evaluation of neurally-mediated (cardioneurogenic) syncope: rationale and proposed protocols. Pacing Clin Electrophysiol 14:1528–1537
Linzer M, Yang EH, Estes NA 3rd, Wang P, Vorperian VR, Kapoor WN (1997) Diagnosing syncope. Part 1: value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 126:989–996
Ferguson DW, Abboud FM, Mark AL (1984) Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation 69:451–460
Stanton CM, Low PA, Hodge DO, Shen WK (2007) Vasovagal syncope in patients with reduced left ventricular function. Clin Auton Res 17:33–38
Mizumaki K, Fujiki A, Tani M, Shimono M, Hayashi H, Inoue H (1995) Left ventricular dimensions and autonomic balance during head-up tilt differ between patients with isoproterenol-dependent and isoproterenol-independent neurally mediated syncope. J Am Coll Cardiol 26:164–173
Brignole M, Menozzi C, Del Rosso A, Costa S, Gaggioli G, Bottoni N, Bartoli P, Sutton R (2000) New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. Europace 2:66–76
Mark AL (1983) The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll of Cardiol 1:90–102
Theodorakis GN, Markianos M, Livanis EG, Zarvalis E, Flevari P, Kremastinos DT (1998) Central serotonergic responsiveness in neurocardiogenic syncope: a clomipramine test challenge. Circulation 98:2724–2730
Theodorakis GN, Markianos M, Zarvalis E, Livanis EG, Flevari P, Kremastinos DT (2000) Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome. J Am Coll Cardiol 36:174–178
Mercader MA, Varghese PJ, Potolicchio SJ, Venkatraman GK, Lee SW (2002) New insights into the mechanism of neurally mediated syncope. Heart 88:217–221
Lambert GW, Kaye DM, Lefkovits J, Jennings GL, Turner AG, Cox HS, Esler MD (1995) Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Circulation 92:1813–1818
Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M (1997) Plasma adenosine levels increase in patients with chronic heart failure. Circulation 95:1363–1365
Shen WK, Hammill SC, Munger TM, Stanton MS, Packer DL, Osborn MJ, Wood DL, Bailey KR, Low PA, Gersh BJ (1996) Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol 28:146–154
Casolo G, Balli E, Fazi A, Gori C, Freni A, Gensini G (1991) Twenty-four-hour spectral analysis of heart rate variability in congestive heart failure secondary to coronary artery disease. Am J Cardiol 67:1154–1158
Linzer M, Yang EH, Estes NA 3rd, Wang P, Vorperian VR, Kapoor WN (1997) Diagnosing syncope. Part 2: unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 127:76–86
Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA (1993) Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 21:110–116
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interest.
Financial support
None.
Rights and permissions
About this article
Cite this article
Yamaguchi, Y., Mizumaki, K., Nishida, K. et al. Vasovagal syncope is associated with poor prognosis in patients with left ventricular dysfunction. Heart Vessels 33, 421–426 (2018). https://doi.org/10.1007/s00380-017-1078-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-017-1078-0